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Abstract
Context—Alternatives to sedative medications are needed to reduce anxiety in mechanically
ventilated patients. Music is an integrative therapy without adverse effects that may alleviate the
anxiety associated with ventilatory support.
Objective—To test whether patient-directed, self-initiated music listening can reduce anxiety and
sedative exposure during ventilatory support in critically ill patients as compared with 2 control
conditions.
Data access and responsibility: Dr. Chlan, principal investigator, had full access to all of the data in the study and takes
responsibility for the integrity of the data and the accuracy of the data analysis.
Author Contributions: Study concept and design: Chlan, Weinert, Heiderscheit, Skaar, Tracy
Acquisitions of data: Chlan, Guttormson, Heiderscheit, Tracy
Analysis and interpretation of the data: Chlan, Savik, Guttormson
Drafting of the manuscript: Chlan, Weinert, Heiderscheit, Skaar, Tracy, Guttormson, Savik
Critical revisions of the manuscript for important intellectual content: Chlan, Weinert, Skaar, Tracy, Guttormson, Savik
Statistical analysis: Savik
Study supervision: Chlan, Weinert, Tracy, Guttormson
Linda Raab Communications LLC provided paid editing assistance on the final version of the first submitted manuscript.
Previous presentation of information: Anxiety data was presented at the Society of Critical Care Medicine's annual congress on
February 5, 2012. The presentation did not address the sedative-exposure aim. The accepted abstract for the SCCM meeting was
submitted with the original version of this manuscript.
Anxiety data from the control usual care group only has been previously published in Nursing Research (2011). A copy of the
published paper was submitted with the original version of this manuscript.
NIH Public Access
Author Manuscript
JAMA. Author manuscript; available in PMC 2014 February 12.
Published in final edited form as:
JAMA. 2013 June 12; 309(22): 2335–2344. doi:10.1001/jama.2013.5670.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Design, Setting, and Patients—Randomized, controlled trial that enrolled 373 ICU patients
from the Minneapolis-St. Paul area receiving acute mechanical-ventilatory support for respiratory
failure between September 2006 and March 2011. Patients were Caucasian (86%), female (52%),
with mean age 59 (SD 14), APACHE III 63 (SD 21.6), on protocol 5.7 (SD 6.4) days.
Intervention—Patients (1) self-initiated music listening (patient-directed music; PDM) with
preferred selections tailored by a music therapist whenever desired while receiving ventilatory
support, (2) self-initiated use of noise-abating headphones (HP), or (3) received usual ICU care
(UC).
Main Outcome Measures—Daily assessments of anxiety (100-mm visual analog scale) and
two aggregate measure of sedative exposure (sedation intensity and sedation frequency).
Results—Mixed-models analysis showed that PDM patients had decreased levels of anxiety
compared with the UC group of −19.5 (p=.003). By the fifth study day anxiety was reduced by
36.5% in PDM patients. The interaction between treatment and time showed PDM significantly
reduced both measures of sedative exposure. PDM reduced sedation intensity by −.18 (−.36, −.
004) points per day and frequency by −.21 (−.37, −.05) points per day compared to UC (p = .05, .
01 respectively). PDM reduced sedation frequency by −.18 (−.36, −.004) points per day compared
to HP (p = .04). By the fifth study day, PDM patients received two fewer sedative doses (reduction
of 38%) and had a reduction of 36% in sedation intensity. There was no significant decline in
sedation intensity compared to HP (p = .32).
Conclusions—Among ICU patients receiving acute ventilatory support for respiratory failure,
self-initiated music resulted in greater reduction in anxiety compared with usual care.
Concurrently, PDM resulted in greater reduction in sedation frequency compared with usual care
or self-initiated noise-abating headphones, and greater reduction in sedation intensity compared
with usual care. Combining a modest reduction in sedative exposure while maintaining a lower
level of anxiety, PDM is an ideal non-pharmacological intervention to improve patients' tolerance
of mechanical ventilation.
Critically ill mechanically ventilated patients (MVPs) receive intravenous sedative and
analgesic medications to reduce anxiety and promote comfort and ventilator synchrony.
These potent medications are often administered at high doses for prolonged periods and are
associated with adverse effects such as bradycardia, hypotension, gut dysmotility,
immobility, weakness, and delirium.1–3 Despite protocols and sedation-assessment tools that
guide clinicians, patients still experience significant levels of anxiety.4,5 Unrelieved anxiety
and fear are not only unpleasant symptoms that clinicians want to palliate, but increased
sympathetic nervous system (SNS) activity can cause dyspnea and increased myocardial
oxygen demand.6 Sustained anxiety and SNS activation can decrease the ability to
concentrate, rest, or relax.6,7 Mechanically ventilated patients have little control over
pharmacological interventions to relieve anxiety; dosing and frequency of sedative and
analgesic medications are controlled by ICU clinicians. Interventions are needed that reduce
anxiety, actively involve patients, and minimize the use of sedative medications.
Non-pharmacological interventions such as relaxing music are effective in reducing anxiety
while reducing medication administration.8,9 Music is a powerful distractor that can alter
perceived levels of anxiety10 by occupying attention channels in the brain with meaningful,
auditory stimuli11 rather than stressful environmental stimuli. Listening to preferred,
relaxing music reduces anxiety in MVPs in limited trials.12–15 It is not known if music can
reduce anxiety throughout the course of ventilatory support, or reduce exposure to sedative
medications. We evaluated if a patient-directed music intervention could reduce anxiety and
sedative exposure in ICU patients receiving mechanical ventilation.
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METHODS
Design
A 3-group, randomized controlled design was used. A computer-generated random numbers
list allocated patients to 1 of 3 groups by each of the 5 participating hospitals: 1) patient-
directed music intervention (PDM); 2) active control with noise-abating headphones only
(HP); or 3) usual ICU care (UC). Group assignment was concealed in an opaque envelope.
Setting
Patients were enrolled from 12 ICUs in 5 hospitals in the Minneapolis-St. Paul area from
September 2006–March 2011.
Sample
Patients were invited to participate in the study if they were: receiving ventilatory support
for acute respiratory failure; alert; participating in their daily care routines; appropriately
following commands; cognitively intact to participate in the consent process; and had
adequate/corrected vision and hearing. Patients were not approached if they were: receiving
aggressive ventilatory support; requiring vasopressors; unresponsive or delirious; receiving
chronic ventilator support prior to hospitalization, or had a documented mental
incompetence (e.g., Alzheimer's disease).
The target sample size of 286 was based on power-analysis calculations that required 48
hours or more of protocol data and allowed for 20% attrition. Other parameters were alpha
= .05 and power = 80%, based on a repeated measures ANCOVA, which provides a good
approximation for mixed models. In prior studies, the visual analog scale-anxiety (VAS-A;
0–100 mm scale) had a mean of 50.5 with SD of 29.2.16 A difference of 15.2 or greater
would be detected as a statistically significant difference between groups. For the sedative-
exposure aim, previous data gave a mean estimate of 6.5 with SD of 4.3.17 Using the sample
size determined for the VAS-A, any difference of 1.8 or greater in the sedation intensity
would be detected as a statistically significant difference between groups.
Study approval was obtained from the University of Minnesota's Institutional Review Board
(IRB) and from the participating hospitals' IRBs. Given the patient-directed nature of the
protocol, the IRB required patients to provide their own written informed consent. To
validate patient understanding of the study's risks, benefits, and procedures, the patient had
to answer 7 “yes or no” questions correctly to the research nurses. If any one of the
questions was answered incorrectly, that patient was not enrolled that day but remained
eligible to be re-approached if mental status improved and inclusion criteria were still met.
Trained research nurses obtained all written consents.
Measures and Instrumentation
Demographic and Study Entry Data—Data were obtained on gender, age, days
mechanically ventilated and ICU days prior to enrollment, diagnoses, ventilator settings, and
all medications received 24 hours prior to enrollment. Data from ICU admission day were
abstracted from the medical record to calculate the Acute Physiology, Age and Chronic
Health Evaluation (APACHE) III score, which was used as a covariate to control for illness
severity.
Anxiety—Anxiety was defined as a state marked by apprehension, agitation, increased
motor activity, arousal, and fearful withdrawal.18 Anxiety was assessed via self-report at
study entry and daily while ventilated using the100-mm VAS-A which was presented to
patients with a vertical orientation like a thermometer. The scale's bottom was anchored by
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the statement “not anxious at all” and the top was anchored by “most anxious ever”. Patients
indicated their current level of anxiety in response to “how are you feeling today?” The
VAS-A score was the number of millimeters from the bottom edge of the line anchor to the
subject's mark. The VAS-A and the Spielberger state anxiety inventory are correlated r = .
4916 to .82,19 demonstrating concurrent validity.
Sedative Exposure—Sedative exposure was determined for all patients who received any
of 8 commonly administered sedative and analgesic medications in the ICU (midazolam,
lorazepam, propofol, dexmedetomidine, morphine, fentanyl, hydromorphone, haloperidol)
24 hours prior to enrollment and each day on protocol. Sedative exposure was
operationalized as a daily sedative drug intensity score and sedative-dose frequency.17 The
usual practice on the participating ICUs consisted of physicians writing orders for sedation
therapy per their individual preferences with the nurses managing administration of these
medications within the parameters of the orders. Sedative administration was not directed by
a specific unit protocol orby a study protocol.
The sedative drug intensity score aggregated dose amounts of medications from disparate
drug classes by using a weight-adjusted dose (adjusting for differing patient weights) of each
sedative administered during 4-hour time blocks during mechanical ventilation. Every drug
amount, for instance, 2 mg of lorazepam administered between noon and 4 pm, was then
placed into quartiles created by using all patients' lorazepam data during their entire time on
the study protocol; 2 mg of lorazepam might fall into quartile 2. If fentanyl was also given at
a dose that fell into quartile 3 for all fentanyl doses within the entire sample, then the noon-4
pm value was 5 (2+3). If none of the 8 medications were given, the value was 0. The values
were summed over the 6 4-hour blocks to produce a daily sedative drug intensity score. For
dose frequency, a 24-hour day was divided into 6 4-hour time blocks and, for each of the 8
drugs, the occurrences in which a sedative was administered at least once during that
interval were summed. This approach to sedative exposure accounts for medications
administered to patients from non-equivalent, disparate drug classes.17
Environmental Scan. The Environmental Scan form was developed for this study to collect
data on the overall activity level in the patient's room each shift and on ICU nursing
experience. Nurses were invited to provide any comments about the study protocol. This
paper and pencil form was adhered to a brightly colored clip-board kept at each participant's
bed side.
Protocol
Experimental PDM Group—A starter set of 6 compact discs (CDs) were reviewed with
the patient by the research nurse to provide for immediate listening upon randomization to
PDM. The starter-set included relaxing music played on piano, harp, guitar, and Native
American flute. The research nurse oriented the patient to CD player and headphone
operation. A standard CD/MP3 player with comfortable, noise-abating headphones was kept
within easy reach to allow the patient to self-initiate music listening.
Within 24 hours of randomization, the music therapist completed a music preference
assessment on each PDM patient using a tool designed to assess music preferences of MVPs
with a simple yes/no format.20 Patients were prompted verbally and with posted signs to use
music at least twice a day when feeling anxious and/or to provide relaxation, but were
encouraged to self-initiate music listening as frequently as desired. Nursing staff were
encouraged to offer music at least twice during their shift, but were reminded by the
research staff that the decision to listen was determined by the patient. A data-logger system
on the headphones captured each PDM session and total daily music-listening time; system
details are described elsewhere.21
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Control Groups—Patients randomized to the active control of noise-abating headphones
(HP) group were encouraged to wear headphones whenever they wanted to block out ICU
noise or have some quiet time. As with the PDM group, HP patients self-initiated headphone
use. Patients randomized to the usual-care (UC) control group received standard ICU care
for that respective unit.
Patients had daily assessment visits by a research nurse who administered the VAS-A.
Patients remained on protocol up to 30 days as long as they were receiving ventilatory
support.
Analysis
Descriptive statistics and graphing were performed on all study data to assess the variables'
distributions. We used bivariate associations to identify covariates to be considered in
subsequent analyses. Covariates were not included to assess their effect per se or adjust for
imbalance among groups, but were included if significantly associated with the outcome to
subtract the variability piece they represent and thus gain efficiency.
Patients with at least 2 days of VAS-A and sedative-exposure data were used in the change
over time analyses. Change over time was assessed as the slope of the outcome variables
determined from one day to the next by the best fitting line. We used mixed-effects models
to analyze anxiety and sedative exposure (sedation intensity scores and sedation frequency)
as they accommodate measures that are correlated from one time point to another and have
variances that are not constant from one time point to another, which would be expected in a
repeated measures analysis of covariance (ANCOVA). This is the recommended modeling
for intent-to-treat analyses.22 Using the data as is within a mixed model analysis has a lower
type I error and higher power than any type of imputation method used for missing data,
which would be needed for a repeated measures ANCOVA. Also, imputation may result in
biased estimates of effects and standard errors. A series of models were estimated and
compared with Aikake's information criterion (AIC) and the Bayesian information criterion
(BIC) to determine the best model of change for the anxiety and sedative-exposure data.
An unconditional means model was used to assess 2 null hypotheses: (a) no change across
occasions; and (b) no variation between subjects. Rejecting these null hypotheses warrants
further analysis.
An unconditional growth model with DAY added as a predictor incorporated estimation of
change coefficients. Models with several within-person error covariance structures that were
compatible with the correlation pattern between anxiety measures and sedative-exposure
measures at different time points were explored. The best fit was the autoregressive +
random effects covariance structure that assumes correlations decrease as the lag time
increases and that covariance also comes from measures within subject. An unconditional
growth model with a quadratic term was also explored to assess if there were non-linear
changes in sedative-exposure measures over time.
A conditional growth model introduced the effect of the intervention and included any
covariates found to be associated with the outcome. These were included in the analysis to
eliminate the variability attached to them and improve the precision of the beta estimates.
Post hoc multiple comparisons were completed within the mixed modeling controlling the
overall alpha level at .05.
We used SPSS v.17 and SAS v.9.2. Final parameter estimates were considered significant at
p ≤ .05 with a 2-sided alpha.
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RESULTS
Demographic Characteristics and Intervention Use Times
Table 1 summarizes the characteristics of patients. Mean age was 59 years with a wide range
of APACHE III scores. The primary indication for mechanical ventilation was respiratory
failure or distress. Only median ICU days prior to enrollment were significantly different at
study entry; HP patients were in the ICU 1–2 days longer prior to enrollment than PDM or
UC patients. Patients remained on protocol for 5.7 (SD 6.4) days (median 3.2; range 1–30).
Figure 1 details subject flow through the study.
PDM patients listened to music for a mean of 79.8 (SD 126) (median (range); 12(0–796)
minutes per day. HP patients wore the noise-abating units for a mean of 34.0 (SD 89.6)
(median (range); 0(0–916) minutes per day. There was no linear relationship between device
use time and anxiety for either PDM (r = .07; p = .14) or HPs (r = −.06; p = .23). More PDM
patients were extubated at the end of the study (Table 1).
Anxiety
The analysis is from the 241 patients with 2 or more anxiety assessments in order to model
change. Not all patients were able to provide anxiety assessments each day due to fatigue,
medical condition, sedated, inability or refusal to complete assessments, or were off the unit
(Figure 1). Unadjusted mean VAS-A was not significantly different among groups at study
entry (Table 1). We did not observe a non-linear pattern or any obvious inflection point in
the individual patterns of change; therefore, change was modeled as linear. Both the
unconditional means model and the unconditional growth model indicated significant
unexplained variance that warranted further modeling. Covariates of interest in the model
were APACHE III, VAS-A at enrollment, and sedative exposure. Two final models were
produced using either sedation frequency or sedation intensity (Table 2). After the
adjustment due to APACHE III and sedation frequency and intensity, the adjusted baseline
VAS-A was different between study groups, and the interaction of baseline with treatment
group was significant. Pair-wise comparisons indicated that PDM patients had a
significantly lower VAS-A score at study entry than UC patients regardless of whether
sedation intensity or frequency was used. Sedation intensity (β = .75(.01, 1.5), p = .05) was
associated with higher VAS-A scores. After adjusting for these covariates, the final models
showed that the main effect of PDM was to lower the VAS-A consistently by more than 19
mm over the study period compared to UC [(β = −19.3(−32, −6.6) sedation intensity, β =
−19.5(−32.2, −6.8) sedation frequency, p = .003, both)] (Figure 2).
Sedative Exposure
The analysis is from the 266 patients who were on protocol for 48+ hours. A linear pattern
of change was supported by graphs of sedation intensity and frequency over time. Sedation
frequency and intensity were not significantly different among groups 24-hours prior to
study entry (Table 1).
Covariates associated with sedation intensity and sedation frequency were age, gender, and
APACHE III scores. Age was significant in both models; the higher the age, the lower the
sedation intensity or sedation frequency. Models showed a significant interaction of the
PDM group and time, showing a decrease in sedation intensity and sedation frequency over
time (per day) for the PDM group only (Table 2). In post hoc pair wise comparisons, the
PDM group had a greater decrease in the change over time of the sedation intensity score
compared to UC (β = −.18(−.36, −.004), p = .05). Using the sedation frequency measure, the
PDM group had a greater decrease in the change over time compared to UC (β = −.21(−.37,
−.05), p = .01) and the HP group (β = −.18(−.36, −.004), p = .04) (Figures 3 and 4).
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For an average patient on the fifth study day (the average time patients were enrolled), a
control patient received 5 doses of any one of the 8 study-defined sedative medications. An
equivalent PDM patient received just 3 doses on the fifth day, a relative reduction of 38%.
By the end of the fifth day, an average control patient had a sedation intensity score of 4.4.
An equivalent PDM patient had a sedation intensity score of 2.8, a relative reduction of
36%. By the end of the fifth day, an average control patient had an anxiety score of 52. An
equivalent PDM patient had an anxiety score of 33 which is an absolute difference of 19 on
a 100 point scale and a relative reduction of 36.5%. Refer to Table 3 for additional details.
Environmental Scan. Nurses caring for patients had a median of 5.9 years (range .25–44
years) ICU experience. When asked to appraise the shift activity in the patient's room, 21%
of the nurses said quiet, 49% said it was at a usual pace, 24% said it was busy, 6% said it
was very busy to hectic. Comments included the nurses' efforts offering PDM or headphones
to patients and their observations of the protocol. Table 4 summarizes these positive
comments about the PDM intervention or headphones use.
COMMENT
The two primary study aims were to determine if patient-directed music reduced anxiety and
sedative exposure in a sample of patients receiving mechanical-ventilatory support. PDM
decreased anxiety and sedative exposure over time more effectively than the control
conditions. To our knowledge these findings are from the first-ever randomized controlled
trial to test an integrative therapy for self-management of anxiety in ventilated ICU patients
that does not rely solely on medications. The unique approach involving patients themselves
in self-management of anxiety launches a novel area of ICU clinical research.
The PDM protocol was modeled after the patient-controlled analgesia intervention whereby
patients report better pain control and are more satisfied when they self-administer analgesic
therapy.8,23,24 Music provides patients with a comforting and familiar stimulus and the
PDM intervention empowers patients in their own anxiety management; it is an inexpensive,
easily implemented non-pharmacologic intervention that can reduce anxiety, reduce sedative
medication exposure and potentially associated adverse effects.25–29 PDM patients received
less frequent and less intense sedative regimens while reporting decreased anxiety levels.
We report a reduction in sedative exposure with PDM using a method to aggregate
medications from disparate drug classes. This is a significant finding in that strategies are
needed to reduce the amount and frequency sedative medications are administered to
mechanically ventilated ICU patients. Appropriately tailored music intervention holds great
promise for use in clinical practice as a method to potentially avoid or reduce the cumulative
adverse side effects of these potent medications, but requires further study..
As more clinicians are advocating to minimize sedative administration,30,31 our data suggest
that patients still experience moderate levels of anxiety. Patients in this study with higher
sedation intensity scores had higher VAS-A scores. This finding is consistent with previous
investigations that demonstrate ICU patients report moderate anxiety levels throughout the
course of ventilatory support, despite receiving sedative medications.7 Given the detrimental
physiological and psychological effects of sustained anxiety, it is important that this
symptom be effectively managed. As clinicians seek “lighter” sedative regimens in the ICU,
PDM may be an appropriate adjunctive intervention by which patients can self-manage
anxiety. There were no comments from nurses that would suggest the study protocol was
burdensome to their patient care practices.
Because patients were enrolled when they were not receiving high levels of sedative
medications (otherwise they would have been too sedated for consenting to enrollment) it is
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difficult to interpret the pharmacological or cost significance of a reduction in sedative
exposure in the days after enrollment compared to the higher doses patients likely received
earlier in their episode of respiratory failure. However, even with a modest reduction in
sedative exposure, patients assigned to PDM also experienced less anxiety compared to
usual care.
There are a number of limitations to this study. Because research nurses completed the
anxiety assessments (to ensure consistent administration and minimize influence on the
bedside nurse's practice), only one anxiety assessment was performed daily. For some
patients the assessment was not performed in relation to use of the PDM intervention, and if
the patient was not available or the patient deferred due to fatigue, medical condition or was
sedated, the assessment was not completed (Figure 1).
Because the intervention was patient-initiated, not all patients randomized to PDM actually
used music twice daily. Some patients may have relied on the bedside nurse to assist with
the equipment. This may have affected the length or frequency of music listening by patients
or the non-significant relationship between music listening time and anxiety. However, even
having the option and availability of PDM may provide patients a sense of control over one
aspect of their ICU care. Given that anxiety is an individually perceived symptom, self-
initiation of treatment with music whenever desired and for as long as desired is the
preferred method of music listening much in the same manner as PCA for pain relief.
Only a small number of nurses provided written comments about the protocol. While
positive, it is unknown if the ICU nurses were reluctant to write negative comments, despite
them being anonymous. We did not query nurses for reasons that they administered sedative
medications to study patients. ICU nurses were not blinded to the assigned group, which
may have introduced bias into the study. Further, we did not collect data from patients after
they were extubated or transferred from the ICU. It is recommended that future research
should include replication of the study with the inclusion of post-ICU outcomes and other
clinically important outcomes.
CONCLUSIONS
Music is an intervention that reduces anxiety and sedative exposure in mechanically
ventilated patients. Because music is an inexpensive non-pharmacological adjunct that
critically ill patients can self-initiate, clinicians should implement music therapy programs in
their ICUs. Further research is needed to determine if music, and other integrative therapies,
can reduce ventilator time, ICU stay, medication costs, and improve post-ICU outcomes.
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Figure 1.
CONSORT Flow Diagram of Study Subjects
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Figure 2.
Visual Analog Scale-Anxiety (VAS-A) Scatterplots by Group
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Figure 3.
Sedation Intensity Scatterplots by Group
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Figure 4.
Sedation Frequency Scatterplots by Group
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Table 1
Demographic and Clinical Characteristics of Subjects (n = 373)
Variable Patient-directed Music
N = 126
Headphones N = 122 Usual Care N = 125 p-value
Mean age (SD) 60.4 (15.4) 59.4 (14.3) 57.8 (13.5) .37
Female gender 68 (54%) 56 (46%) 69 (55%) .28
Mean APACHE III (SD) 63.1 (18.7) 62.2 (22.3) 65.6 (23.5) .43
Median ICU days prior to study entry (range) 6(0–40) 8(1–85) 7(0–33)
.02 *
Median ventilator days prior to study entry (range) 4.5(0–35) 6(1–79) 6(0–38) .11
Median ventilator days total (prior + study days) 7.5 (1–53) 7.3 (1–47) 7.7 (1–46) .74
Median days enrolled on protocol (range) 3 (1–27) 3.6 (1–30) 3.8 (1–30) .66
Mean study entry VAS-A mm(SD) 51.9mm(32.4) 49.0mm(30.1) 52.3mm(29.7) .66
Median sedation intensity score 24 hours prior to
enrollment (range)
4.0(0–12) 3.5(0–10) 4.0(0–12) .07
Median sedation frequency 24 hours prior to
enrollment (range)
7.0(0–18) 6.0(0–19) 6.0(0–14) .14
Extubated at end of study 89 (72%) 67 (56%) 83 (67%)
.02 *
Alive at end of study 115(94%) 111(93%) 109(89%) .65
Primary ICU Admission Diagnosis Category Number (%) Number (%) Number (%)
Pulmonary 77(6) 70(58) 71(57)
Cardiac-medical 14 (11) 9(7) 9(7)
Sepsis/infection 10(8) 7(6( 6(4)
Gastrointestinal 6(5) 8(7) 7(6)
Neurological or neuromuscular 2(2) 6(5) 7(6)
Oncology 4(3) 3(2) 4(3)
Shock/hypotension 3(2) 2(2) 5(4)
Trauma 3(2) 4(3) 2(2)
Cardiac Surgical 0 3(2) 3(2)
Surgical 2(2) 3(2) 0
Vascular 2(2) 0 2(2)
Other or missing 3(2) 7(6) 9(7)
Indication for Mechanical Ventilation Number (%) Number (%) Number (%)
Respiratory failure 63(50) 63(52) 61(49)
Respiratory distress 32(25) 27(22) 36(29)
Pneumonia 7(6) 5(4) 7(6)
Respiratory arrest 3(2) 4(3) 4(3)
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Variable Patient-directed Music
N = 126
Headphones N = 122 Usual Care N = 125 p-value
Airway protection 2(1) 5(4) 4(3)
Surgery-post-operative 2(1) 3(3) 4(3)
COPD 7(6) 4(3) 0
Hypoxia 2(1) 3(3) 2(2)
ARDS 1(1) 1(1) 0
Tachypnea 1(1) 0 1(1)
Cardiac arrest 4(3) 2(2) 5(4)
Pulmonary edema 1(1) 0 0
Asthma 0 0 1(1)
Other or missing 1(1) 5(4) 0
Abbreviations: APACHE III, Acute Physiology, Age and Chronic Health Evaluation III; VAS-A, Visual Analog Scale-Anxiety
*p<.05
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Table 2
Final models for Anxiety and Sedative Exposure (≥ 2 days of data)
Model Results VAS-A
Sedation frequency N = 241
Model Results VAS-A
Sedation frequency N = 241
Model Results Sedation
intensity N = 266
Model Results Sedation
frequency N = 266
β(95% CI)
Change in mm
for VAS-A for 1
unit change in
predictor
p-value β(95% CI)
Change in mm
for VAS-A for 1
unit change in
predictor
p-value β(95% CI)
Change in
sedation
intensity for 1
unit change in
predictor
p-value β(95% CI)
Change in
sedation
frequency for 1
unit change in
predictor
p-value
Intercept 35.6(23.3, 48.0) <.001 34.9(22.6,47.2) <.001 5.3(3.5,7.1) <.001 7.3(5.1,9.5) <.001
Day −.50(−1.1, .05) .08 −.51(−1.1,.04) .07 −.03(−.15,.09) .65 −.17(−.27, −.07) <.001
VAS-A day 0 .11(−.05, .27) .18 .11(−.05,.27) .18
PDM −19.5(−32.2, −6.8) .003* −19.3(−32.0,−6.6) .003* .14(−.92,1.2) .79 .69(−.68,2.1) .33
HP −8.3(−21.4, 4.8) .22 −8.3(−8.7,−7.9) .21 18(−.86, 1.2) .73 −.01(−1.3,1.3) .99
APACHE III .16(.02, .30) .02* .16(.02,.30) .02* .003(−.01.02) .79 .005(−.01,.02) .65
Age −.03(−.05, −.01) .03* −.04(−.08,−.008) .03*
sex 88(.15,1.6) .02* .94(.02,1.9) .047*
PDM * day −.18(−.36,−.004) .05 −.21(−.37,−.05) .01*
HP * day −08(−.24,.08) .32 −.03(−.17,.11) .72
Adj sedation intensity .75(.01,1.5) .05
Adj sedation frequency .42(−.15, .99) .14
PDM*VAS-A day 0 .25(.03, .47) .02* .25(.03,.47) .02*
HP*VAS-A day 0 .11(−.13, .35) .33 .12(−.12,.36) .32
Pair-wise comparisons
VAS-A day 0 VAS-A day 0 Sedation intensity Sedation Frequency
PDM vs HP .14(−.08,.36) .24 .13(−.09,.35) .24 −.09(−.27,.09) .32 −.18(−.36,−004) .04
PDM vs UC .25(.03,.47) .02* .25(.03,.47) .02* −.18(−.36,−.004) .05* −.21(−.37,−.05) .01*
HP vs UC .11(−.13,.35) .33 .12(−.12,.36) .32 −.08(−.24,.08) .32 −.03(−.17, .11) .72
Abbreviations: PDM, patient-directed music; HP, headphones; UC, usual care; Adj, adjusted ; APACHE III, Acute physiology, age and chronic
health evaluation. Example of interpretation of table: formula to predict sedation frequency for PDM group at any time point:
Sedation Frequency = 7.3 −.17(day in study) −.21(day if in PDM group) + .69(if in PDM group) + .005(APACHE III score) −.04(age) + .94(if
female). The intercept represents the overall average of frequency sedation at baseline, 7.3 doses. Every patient goes down an average of .17 doses
per day, if the patient is in the PDM group, for each day, the dose frequency goes down another .21 points for (.17 + .21 = .38) decrease per day. If
the patient was in the PDM group, the baseline average was .69 higher (7.3+.69 = 7.99), every increase of 1 point in the APACHE III score raises
the total daily dose frequency another .005. For every 1 year older a patient is, their sedation frequency goes down .04 pts. If the patient is female,
the dose frequency goes up .94.
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Table 4
Summary of ICU Nurse Comments and Observations Concerning Study Protocol
Randomized Group Written Nurse Comments and Observations
Patient-directed music Patient's wife says he listens to the music all of the time and it has been working well. Patient was sleeping with
headphones on with his wife sleeping next to him in a chair.
Patient looks very peaceful and states she likes the music.
Patient was tapping fingers to some of the music provided to him by the music therapist.
Patient listened to music most of yesterday (about 10 hours). Tends to be anxious and her blood pressure is lower
when she is listening to music.
Patient likes music and always nods head “yes” to have headphones in place when asked.
After putting headphones on, patient appears less anxious.
Patient wears headphones very often and rests well with them in place. Always nods `yes' to wearing headphones.
Patient has been tapping feet to the music and listens for a couple of hours each night; seems happy with it!
After putting headphones on, patient appears less anxious.
Able to decrease propofol slightly.
Evening was quieter. Patient put headset on which seemed to help a lot.
Family visited for 1 hour. Patient had difficulty sleeping; tried reading and quiet time before using headphones.
Patient calm and resting on headphones.
Patient was relaxing with music on for 3 hours.
Patient slept well, headphones for 3 hours.
Music was on entire night (8 hour shift)
Headphones Only Patient really benefited from headphones!
Patient relaxed with headphones
I'm glad he's participating. I think the headphones will help him rest.
The headphones would help her get more rest (due to the commotion on the other side of the curtain with
roommate).
The patient wanted to wear the headphones most of the day yesterday and communicated that they helped her rest.
Patient put headphones on without prompting.
Headphones helped patient sleep during dialysis.
Patient wanted to wear headphones all night.
Patient had earphones on about 1 hour early in the night, then declined to use them rest of night.
Headphones decrease nerves per patient and patient's wife.
Patient appeared calmer with headphones on.
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